Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients (Q64183801)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients |
clinical trial |
Statements
Rivaroxaban Versus Low-molecular-weight Heparin in Preventing Thrombosis Among Cancer Patients After Femoral Venepuncture (English)
0 references
16 February 2016
0 references
30 June 2018
0 references
74
0 references
18 year
0 references
85 year
0 references